InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Brager David A., Director. Officer active across 2 companies, notably CVB FINANCIAL CORP. In total, 13 filings have been published. The latest transaction was filed on 25 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€42,9961,974 shares@ €21.7810.0017% mcap13.0% of flow
Common Stock
SEC:0001567619-22-007622:0·
021,350 shares0
Common Stock
SEC:0001567619-22-001940:0·
€67,5323,408 shares@ €19.815847.0% of flow
Common Stock
SEC:0001567619-22-001967·
021,350 shares0
Common Stock
SEC:0001567619-22-001940·
€67,5323,408 shares@ €19.81580.0027% mcap20.5% of flow
Common Stock
SEC:0001567619-22-001967:0·
020,850 shares0
Common Stock
SEC:0001567619-22-001881·
020,850 shares0
Common Stock
SEC:0001567619-22-001881:0·
€9,376519 shares@ €18.06560.0004% mcap2.8% of flow
Common Stock
SEC:0001567619-21-020708·
€9,376519 shares@ €18.06560.0004% mcap2.8% of flow
Common Stock
SEC:0001567619-21-020708:0·
€25,5291,496 shares@ €17.06517.8% of flow
Common Stock
SEC:0001567619-21-018506·
€25,5291,496 shares@ €17.0650.0010% mcap7.7% of flow
Common Stock
SEC:0001567619-21-018506:0·
€41,1552,500 shares@ €16.462228.7% of flow
Common Stock
SEC:0001567619-21-017420·
€41,1552,500 shares@ €16.46220.0016% mcap12.5% of flow
Common Stock
SEC:0001567619-21-017420:0·
13 of 13 declarations
About Brager David A.
Franklin M. Berger is a Board Member at Kezar Life Sciences, Inc. and Rain Therapeutics Inc. He brings expertise in biopharmaceutical strategy to the board. His role involves overseeing growth initiatives and ensuring that operations align with the company's goals.
